Michelle Dookwah
Overview
Explore the profile of Michelle Dookwah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dookwah M, Wagner S, Ishihara M, Yu S, Ulrichs H, Kulik M, et al.
Hum Mol Genet
. 2023 Sep;
32(24):3323-3341.
PMID: 37676252
GM3 Synthase Deficiency (GM3SD) is a neurodevelopmental disorder resulting from pathogenic variants in the ST3GAL5 gene, which encodes GM3 synthase, a glycosphingolipid (GSL)-specific sialyltransferase. This enzyme adds a sialic acid...
2.
Ozdilek A, Paschall A, Dookwah M, Tiemeyer M, Avci F
Proc Natl Acad Sci U S A
. 2020 Jan;
117(3):1280-1282.
PMID: 31907319
Nucleic acid vaccines introduce the genetic materials encoding antigenic proteins into host cells. If these proteins are directed into the secretory pathway with a signal/leader sequence, they will be exposed...
3.
Berger R, Dookwah M, Steet R, Dalton S
Bioessays
. 2016 Sep;
38(12):1255-1265.
PMID: 27667795
Glycosylation refers to the co- and post-translational modification of protein and lipids by monosaccharides or oligosaccharide chains. The surface of mammalian cells is decorated by a heterogeneous and highly complex...
4.
Parkinson W, Dookwah M, Dear M, Gatto C, Aoki K, Tiemeyer M, et al.
Dis Model Mech
. 2016 Mar;
9(5):513-27.
PMID: 26940433
Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation...
5.
McVeigh T, Jung S, Kerin M, Salzman D, Nallur S, Nemec A, et al.
Cell Cycle
. 2015 May;
14(13):2091-9.
PMID: 25961464
The KRAS-variant is a biologically functional, microRNA binding site variant, which predicts increased cancer risk especially for women. Because external exposures, such as chemotherapy, differentially impact the effect of this...